From Name:
From Email:
To Name:
To Email:

Optional Message:

Electronic device adds to glioma survival

from MedPage Today

Survival in newly diagnosed glioblastoma improved significantly in patients who used an electrical energy-emitting device in addition to receiving standard chemotherapy, final results of a randomized trial showed. Patients who used the tumor-treating fields (TTFields) device in addition to adjuvant temozolomide (Temodar) had a median overall survival (OS) of 21 months compared with 16 months for patients treated with chemotherapy alone. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063